By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Deltagen Inc. (DGEN)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$3.86K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

DGEN Stock Price Chart

Explore Deltagen Inc. interactive price chart. Choose custom timeframes to analyze DGEN price movements and trends.

DGEN Company Profile

Discover essential business fundamentals and corporate details for Deltagen Inc. (DGEN) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

3 Aug 2000

Employees

CEO

Robert J. Driscoll

Description

Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.

DGEN Financial Timeline

Browse a chronological timeline of Deltagen Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

DGEN Stock Performance

Access detailed DGEN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run